
Metagenomi Leverages AWS AI to Accelerate Gene Editing Research
Biotech pioneer Metagenomi leverages AWS AI to accelerate gene editing research, transforming the discovery of novel therapeutics. The company now analyzes a proprietary 15billionprotein database in hours a task that previously took as long as processing a single bacterial genome, according to an HPCwire report. By pairing AIdriven metagenomic mining with purposebuilt cloud infrastructure, Metagenomi is building a powerful gene editing toolbox to target diseases with no curative options.













